1. Immunogenicity of biotherapeutics – an overview;Subramanyam;J Immunotoxicol,2006
2. Immunotoxicity and immunogenicity of biopharmaceuticals: design concepts and safety assessment;Bhogal;Curr Drug Saf,2010
3. The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation;Cleland;Crit Rev Ther Drug Carrier Syst,1993
4. Subcutaneous interleukin-2 and interferon-alpha 2b in patients with metastatic renal cell cancer: the German outpatient experience;Kirchner;Mol Biother,1990
5. Immunogenicity of therapeutic proteins;Schellekens;Nephrol Dial Transplant,2003